Advanced Search

Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 41.06 8.05% 3.06
ODT closed up 8.05 percent on Monday, August 10, 2020, on 1.14 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical ODT trend table...
Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Multiple of Ten Bullish Other 0.00%
Upper Bollinger Band Touch Strength 0.00%
50 DMA Resistance Bearish 8.05%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 8.05%
Crossed Above 20 DMA Bullish 8.05%
MACD Bullish Signal Line Cross Bullish 8.05%
Outside Day Range Expansion 8.05%
Fell Below 20 DMA Bearish 10.23%
Older EOD signals for ODT ...
View Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Cancer Pharmaceutical Iowa Spotlight Innovation Urbandale

Is ODT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Aug 6 Are Options Traders Betting on a Big Move in Odonate Therapeutics (ODT) Stock?
Jul 30 Odonate Therapeutics EPS misses by $0.08
Jul 30 Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2020
Jul 1 Hedge Funds Dropped The Ball On Odonate Therapeutics, Inc. (ODT)
Jun 18 The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
Jun 17 The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
May 29 Odonate Therapeutics to Present at the Jefferies Virtual Healthcare Conference
May 13 Were Hedge Funds Right About Odonate Therapeutics, Inc. (ODT)?
Apr 28 Odonate Therapeutics EPS beats by $0.01
Apr 28 Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2020
See more ODT news...

Indicators

Indicator Value
52 Week High 46.4999
52 Week Low 18.07
Average Volume 96,034
200-Day Moving Average 32.21
50-Day Moving Average 38.97
20-Day Moving Average 38.04
10-Day Moving Average 37.26
Average True Range 2.11
ADX 15.06
+DI 26.97
-DI 14.88
Chandelier Exit (Long, 3 ATRs ) 35.63
Chandelier Exit (Short, 3 ATRs ) 41.08
Upper Bollinger Band 41.48
Lower Bollinger Band 34.59
Percent B (%b) 0.94
BandWidth 18.12
MACD Line -0.09
MACD Signal Line -0.36
MACD Histogram 0.2738
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.31
Resistance 3 (R3) 45.96 43.85 45.44
Resistance 2 (R2) 43.85 42.52 44.03 45.14
Resistance 1 (R1) 42.46 41.69 43.16 42.81 44.85
Pivot Point 40.35 40.35 40.70 40.53 40.35
Support 1 (S1) 38.96 39.02 39.66 39.31 37.27
Support 2 (S2) 36.85 38.19 37.03 36.98
Support 3 (S3) 35.46 36.85 36.69
Support 4 (S4) 35.81